Charles Lee Nuzum Sr serves as Executive at Predictive Oncology Inc., where they oversee executive responsibilities. Since joining the company, Charles Lee Nuzum Sr has executed 17 insider transactions totaling $92.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 9, 2025 involved receiving (via award) 64,680 shares valued at $0.
Charles Lee Nuzum Sr currently holds 94,587 shares of Predictive Oncology Inc. (POAI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Charles Lee Nuzum Sr has been a net buyer of POAI stock. They have purchased $62.0K and sold $30.4K worth of shares.
Charles Lee Nuzum Sr's most recent insider trade was on Sep 9, 2025, when they sold 64,680 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 2, 2023 | POAI | $0 | Award | 2,605 | $N/A | Discretionary |
| Sep 25, 2023 | POAI | $30.4K | Sale | 10,000 | $3.04 | Discretionary |
| Jul 3, 2023 | POAI | $0 | Award | 3,773 | $N/A | Discretionary |
| Apr 3, 2023 | POAI | $0 | Award | 25,499 | $N/A | Discretionary |
| Jan 25, 2023 | POAI | $0 | Award | 53,539 | $N/A | Discretionary |
| Jan 3, 2023 | POAI | $0 | Award | 172,150 | $N/A | Discretionary |
| Oct 3, 2022 | POAI | $0 | Award | 23,147 | $N/A | Discretionary |
| Jul 1, 2022 | POAI | $0 | Award | 44,704 | $N/A | Discretionary |
| May 20, 2022 | POAI | $62.0K | Purchase | 200,000 | $0.31 | Discretionary |
| Mar 31, 2022 | POAI | $0 | Award | 8,530 | $N/A | Discretionary |
| Jan 4, 2022 | POAI | $0 | Award | 43,775 | $N/A | Discretionary |
| Oct 1, 2021 | POAI | $0 | Award | 6,265 | $N/A | Discretionary |
| Jul 1, 2021 | POAI | $0 | Award | 13,995 | $N/A | Discretionary |
| Apr 1, 2021 | POAI | $0 | Award | 6,887 | $N/A | Discretionary |
| Jul 10, 2020 | POAI | $0 | Award | 6,712 | $N/A | Discretionary |